Spotlight on Genetic Kidney Diseases: A Call for Drug Delivery and Nanomedicine Solutions

被引：22

作者：

Trac, Noah ^{[1
]}

Ashraf, Anisa ^{[1
]}

Giblin, Joshua ^{[1
]}

Prakash, Supriya ^{[2
,3
]}

Mitragotri, Samir ^{[2
,3
]}

Chung, Eun Ji ^{[1
,4
,5
,6
]}

机构：

[1] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA

[2] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Allston, MA 02134 USA

[3] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA

[4] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA

[5] Univ Southern Calif, Dept Med,Eli & Edythe Broad Ctr Regenerat Med & S, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA

[6] Univ Southern Calif, Dept Surg, Div Vasc Surg & Endovasc Therapy, Keck Sch Med, Los Angeles, CA 90033 USA

来源：

ACS NANO | 2023年 / 17卷 / 07期

关键词：

genetic kidney disease; congenital disease; nanomedicine; cell therapy; drug delivery; rare diseases; IN-VITRO SELECTION; NANOPARTICLES; PEPTIDE; CELLS; PLACENTA; THERAPY; LIGANDS; DNA; OPPORTUNITIES; STRATEGIES;

D O I：

10.1021/acsnano.2c12140

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Nanoparticles as drug delivery carriers have benefited diseases, including cancer, since the 1990s, and more recently, their promise to quickly and efficiently be mobilized to fight against global diseases such as in the COVID-19 pandemic have been proven. Despite these success stories, there are limited nanomedicine efforts for chronic kidney diseases (CKDs), which affect 844 million people worldwide and can be linked to a variety of genetic kidney diseases. In this Perspective, we provide a brief overview of the clinical status of genetic kidney diseases, background on kidney physiology and a summary of nanoparticle design that enable kidney access and targeting, and emerging technological strategies that can be applied for genetic kidney diseases, including rare and congenital kidney diseases. Finally, we conclude by discussing gaps in knowledge remaining in both genetic kidney diseases and kidney nanomedicine and collective efforts that are needed to bring together stakeholders from diverse expertise and industries to enable the development of the most relevant drug delivery strategies that can make an impact in the clinic.

引用

页码：6165 / 6177

页数：13

共 95 条

[81]

Watson S., 2022, ALPORT SYNDROME

[82] Selective Nanoparticle Targeting of the Renal Tubules [J].

Williams, Ryan M. ;

Shah, Janki ;

Tian, Helen S. ;

Chen, Xi ;

Geissmann, Frederic ;

Jaimes, Edgar A. ;

Heller, Daniel A. .

HYPERTENSION, 2018, 71 (01) :87-94

[83] Nanomedicines for kidney diseases [J].

Williams, Ryan M. ;

Jaimes, Edgar A. ;

Heller, Daniel A. .

KIDNEY INTERNATIONAL, 2016, 90 (04) :740-745

[84] Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium [J].

Williams, Ryan M. ;

Shah, Janki ;

Ng, Brandon D. ;

Minton, Denise R. ;

Gudas, Lorraine J. ;

Park, Christopher Y. ;

Heller, Daniel A. .

NANO LETTERS, 2015, 15 (04) :2358-2364

[85] Long-Term Outcomes of Kidney Transplantation in Children [J].

Winterberg, Pamela D. ;

Garro, Rouba .

PEDIATRIC CLINICS OF NORTH AMERICA, 2019, 66 (01) :269-+

[86] Current advances of stem cell-based therapy for kidney diseases [J].

Wong, Chee-Yin .

WORLD JOURNAL OF STEM CELLS, 2021, 13 (07) :914-933

[87] Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer [J].

Xu, Wenjin ;

Siddiqui, Imtiaz A. ;

Nihal, Minakshi ;

Pilla, Srikanth ;

Rosenthal, Kimberly ;

Mukhtar, Hasan ;

Gong, Shaoqin .

BIOMATERIALS, 2013, 34 (21) :5244-5253

[88] Adult human kidney organoids originate from CD24+ cells and represent an advanced model for adult polycystic kidney disease [J].

Xu, Yaoxian ;

Kuppe, Christoph ;

Perales-Paton, Javier ;

Hayat, Sikander ;

Kranz, Jennifer ;

Abdallah, Ali T. ;

Nagai, James ;

Li, Zhijian ;

Peisker, Fabian ;

Saritas, Turgay ;

Halder, Maurice ;

Menzel, Sylvia ;

Hoeft, Konrad ;

Kenter, Annegien ;

Kim, Hyojin ;

van Roeyen, Claudia R. C. ;

Lehrke, Michael ;

Moellmann, Julia ;

Speer, Thimoteus ;

Buhl, Eva M. ;

Hoogenboezem, Remco ;

Boor, Peter ;

Jansen, Jitske ;

Knopp, Cordula ;

Kurth, Ingo ;

Smeets, Bart ;

Bindels, Eric ;

Reinders, Marlies E. J. ;

Baan, Carla ;

Gribnau, Joost ;

Hoorn, Ewout J. ;

Steffens, Joachim ;

Huber, Tobias B. ;

Costa, Ivan ;

Floege, Jurgen ;

Schneider, Rebekka K. ;

Saez-Rodriguez, Julio ;

Freedman, Benjamin S. ;

Kramann, Rafael .

NATURE GENETICS, 2022, 54 (11) :1690-+

[89]

Yamashita K, 2011, NAT NANOTECHNOL, V6, P321, DOI [10.1038/nnano.2011.41, 10.1038/NNANO.2011.41]

[90] Cystin genetic variants cause autosomal recessive polycystic kidney disease associated with altered Myc expression [J].

Yang, Chaozhe ;

Harafuji, Naoe ;

O'Connor, Amber K. ;

Kesterson, Robert A. ;

Watts, Jacob A. ;

Majmundar, Amar J. ;

Braun, Daniela A. ;

Lek, Monkol ;

Laricchia, Kristen M. ;

Fathy, Hanan M. ;

Mane, Shrikant ;

Shril, Shirlee ;

Hildebrandt, Friedhelm ;

Guay-Woodford, Lisa M. .

SCIENTIFIC REPORTS, 2021, 11 (01)

← 1 2 3 4 5 6 7 8 9 10 →